FDA Warns About Deadly Allergic Reaction to Chlorhexidine Gluconate

February 27, 2017

The Food and Drug Administ­ration (FDA) has issued a request for manufacturers of over-the-counter (OTC) antiseptic products containing chlorhexidine gluconate to add a warning of a possible allergic reaction risk. This request follows a rise in reports of serious allergic reactions in recent years.
Found in products to clean skin, chlorhexidine gluconate has been associated with 43 cases of anaphylaxis (a severe allergic reaction) worldwide from January 1969–June 2015, according to the FDA. More than 50% of cases were reported after 2010, with the potential for additional cases not reported to the FDA. Two deaths are attributed to allergic reactions to chlorhexidine gluconate.
Chlorhexidine gluconate can be found in swabs, solutions, sponges, oral chips and mouthwashes created to reduce bacteria and avoid potential skin infections, both OTC and with a prescription. The products are used before surgery and injections, including fillers and other medical spa procedures.
Read more at Skin Inc. Magazine >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Compounded Tirzepatide, NAD+ Injections Recalled Nationwide Over Sterility Concerns
    • Meliora Consulting Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Sends Peptide ‘Interim Access Policy’ to White House for Review
    • New ACOG Menopause Guidelines Expand Hormone Therapy and Symptom Treatment Recommendations
    • Galderma to Acquire ZO Skin Health for $1.5 Billion